Mozambique: Supporting Indigenous Organizations to implement and Expand Comprehensive HIV/AIDS Prevention, Care and Treatment in the Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR) | Apply Online

Frequently Asked Questions (FAQs)

What is this funding opportunity?

This is a supplemental cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC), released under PEPFAR. It is intended to strengthen and expand comprehensive HIV/AIDS prevention, care, and treatment efforts in Mozambique by adding resources to work that is already ongoing.

Is this an open, competitive grant opportunity?

No. The opportunity is explicitly limited in eligibility to a single indigenous implementer: the Ariel Foundation in Mozambique. It is not a competitive open call for multiple organizations.

Who is eligible to apply?

Eligibility is limited to the Ariel Foundation in Mozambique (a single indigenous implementer). Based on the information provided, other organizations are not eligible under this notice.

What does “supplemental” mean in this context?

“Supplemental” indicates the funding is designed to add resources to existing, ongoing work rather than to launch a brand-new standalone project. The intent is to extend and intensify current activities to reach accelerated targets.

What is the main purpose of the supplemental award?

The purpose is to strengthen and expand HIV/AIDS prevention, care, and treatment services in Mozambique, with an emphasis on accelerating progress toward epidemic control by increasing coverage of high-impact interventions in prioritized districts.

What public health situation is this award responding to?

The award is framed in response to Mozambique’s generalized HIV epidemic, including an estimated adult HIV prevalence of about 11.5 percent among people ages 15 to 49, along with one of the most severe health care worker shortages globally.

How does this opportunity relate to PEPFAR?

The opportunity is released under PEPFAR and is described as part of PEPFAR’s “accelerated plan,” which prioritizes rapid delivery of a core package of high-impact interventions in selected geographic areas to move faster toward epidemic control.

What specific targets or frameworks does the program align with?

The program is aligned with the UNAIDS Fast-Track framework and the 90-90-90 targets, which emphasize diagnosing people living with HIV, initiating and sustaining antiretroviral treatment, and achieving viral suppression at scale.

What service delivery goals are highlighted for targeted districts?

The notice emphasizes increasing coverage toward PEPFAR acceleration goals in prioritized districts, including expanding HIV treatment coverage to reach an 80 percent benchmark in targeted districts.

Which HIV services or interventions are emphasized?

The supplemental award highlights scaling up HIV testing and counseling, prevention of mother-to-child transmission (PMTCT) services, and voluntary medical male circumcision (VMMC), alongside expanded HIV treatment coverage.

How does the opportunity connect to the idea of an “AIDS-Free Generation”?

The award aligns with PEPFAR’s AIDS-Free Generation policy by reinforcing the emphasis on preventing new infections, keeping people living with HIV healthy through effective treatment, and reducing HIV-related deaths through earlier diagnosis and sustained care.

Where will the supplemental activities take place?

The supplemental activities focus on Cabo Delgado Province and Maputo Province in Mozambique, building on the Ariel Foundation’s current portfolio in those areas.

Does this funding support work nationwide in Mozambique or only specific areas?

Based on the information provided, the supplemental activities are focused on prioritized districts within Cabo Delgado Province and Maputo Province rather than being described as a nationwide effort.

What type of award mechanism is being used?

The mechanism is a cooperative agreement. This typically indicates substantial involvement from CDC in technical direction, monitoring, and collaboration during implementation.

What does “substantial involvement” from CDC imply here?

It implies CDC is expected to be actively involved in technical direction, monitoring, and collaboration, which is common for PEPFAR-supported programs where measurable service delivery and outcomes are central.

What is the funding opportunity number and CFDA listing?

The opportunity is listed as CDC RFA GH11-1130SUPP16 with CFDA 93.067.

When was this opportunity posted and when did it close?

It was posted on January 8, 2016, and had a closing date of March 8, 2016.

How many awards were expected?

The notice indicates an expectation of a single award, consistent with the eligibility restriction to one implementer.

The notice shows an “award ceiling” of 0. Does that mean there is no funding?

Not necessarily. The information provided indicates the “0” ceiling likely reflects how the posting captured ceiling data rather than implying no funding. The key point is that it is a single-recipient supplemental action intended to accelerate delivery of core HIV services.

Is this funding intended to start new programming or expand existing efforts?

It is intended to expand and intensify existing efforts by adding resources to ongoing work already underway through the Ariel Foundation’s current portfolio.

What is the overall “takeaway” from the listing?

The main takeaway is that this is a single-recipient, supplemental cooperative agreement under PEPFAR intended to accelerate delivery of core HIV prevention, care, and treatment services in prioritized districts in Cabo Delgado and Maputo provinces, with CDC playing a substantial technical and monitoring role.